NCT00709644View on ClinicalTrials.gov

Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

August 31, 2005

Conditions
PharmacokineticsTherapeutic EquivalencyContraceptives, Oral
Interventions
DRUG

Norgestimate; Ethinyl Estradiol; Folic acid.

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00709644 - Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. | Biotech Hunter | Biotech Hunter